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Identifying certain animal 
diseases as “neglected”
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The “neglected” status given by the World Health Organization (WHO) to certain 
endemic tropical diseases, both human and zoonotic, affecting poor populations 
has resulted in the large-scale mobilisation of stakeholders and resources, 
thereby improving control of these diseases.
Hence the proposal to also recognise as “neglected” certain animal diseases with 
serious socio-economic impacts on marginalised populations in the least 
developed countries. This process nevertheless requires prior identification of 
economic and social impacts, as well as of the criteria and threshold from which 
this recognition should be applied.
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Unlike emerging diseases (avian influenza, Ebola, etc.), some endemic tropical diseases fail to mobilise policy makers 
and public and private stakeholders. Research 
is unable to secure sufficient long-term finan-
cing; the public authorities and the private 
sector make little or no investment in the 
production of treatments and vaccines, or in 
control and surveillance, which receive only 
0.6% of all global expenditure on health.
However, according to the World Health 
Organization (WHO), these diseases affect 
almost 1 billion people in low-income econo-
mies, mainly livestock farmers and family far-
mers, who have poor health and no access to 
preventive measures or treatments, should 
these exist. Most of these people live in the least 
developed countries, where the tropical or 
sub-tropical climates are favourable to infec-
tious and parasitic diseases and effective health 
systems are lacking. Consequently, socio- 
economic development is held back, even 
though a small amount of investment would 
often be enough to control or eradicate some 
of these diseases. When drugs and vaccines are 
available, rapid improvements can be made, 
provided there is an organised health system, 
whether public, private or mixed.
Noting the persistence of these communicable 
diseases that sustain poverty, and in order to 
mobilise the resources required to provide 





populations, WHO identified 17 tropical 
diseases as “neglected” (NTDs), including five 
zoonotic diseases (T. solium cysticercosis, echi-
nococcosis, leishmaniasis, rabies, and human 
African trypanosomiasis, or sleeping sickness). 
It should be noted that three zoonoses 
(anthrax, bovine tuberculosis and brucellosis), 
whose status is unclear, are however considered 
by some authors as neglected.
However, no strictly animal (non-zoonotic) 
disease has been identified as “neglected” by 
the international organisations. Like NTDs, 
some nevertheless negatively impact on the 
poor, especially in remote areas far from the 
centres of power and services: livestock mor-
tality and the decrease in production and pro-
duct quality (meat, milk, leather) result in a loss 
of income, affecting food security, health and 
education. The risks incurred prevent livestock 
farmers from investing, meaning they remain 
in the poverty trap.
Official recognition of neglected disease status 
could therefore be beneficial in preventing 
certain risks, and controlling or even eradicat-
ing diseases with the highest social and eco-
nomic impacts. It would enable the 
mobilisation of public and private resources for 
research (treatments, vaccines, risk factor iden-
tification, predictive modelling, socio-econo-
mic impact assessments, etc.) and the 
implementation of preventive measures (risk 
analysis, surveillance, farm biosecurity).
The benefits of identifying 
diseases as “neglected”
For the 17 NTDs, this recognition has resulted 
in substantial mobilisation: the Global Plan 
2008-2015, then the 2012-2020 roadmap 
implemented by WHO; and the 2012 London 
Declaration, in which a coalition of pharma-
ceutical companies, public and private donors, 
national programmes and NGOs committed 
to eradicating 10 of the 17 NTDs by 2020.
Sleeping sickness, one of the 10 NTDs targe-
ted by the London Declaration, is emblematic 
in this respect. In order to address the growing 
number of victims (300 000 people infected in 
the early 1990s) and of people exposed 
(60 million in Africa), human African trypa-
nosomiasis became the subject of coordinated 
efforts, after being neglected for several 
decades. WHO mobilised stakeholders: senior 
government officials; donors (Gates Foundation, 
DFID); research centres; and pharmaceutical 
companies, which committed to providing 
medicines free of charge to WHO in order for 
the organisation to distribute them. Stakehol-
ders reorganised their operations. The result of 
this mobilisation is that the upward trend has 
been reversed: in 2012, fewer than 8 000 cases 
were reported. This success led WHO to 
include human African trypanosomiasis in its 
roadmap with the goal of eradicating it as a 
public health problem by 2020.
For other zoonoses, the “neglected” status has 
facilitated progress in research, financing and 
the mobilisation of the stakeholders concer-
ned, and has helped to curb the collapse of 
expertise. One example, human rabies trans-
mitted by dogs, is still present in tropical zones 
despite the existence of effective means of 
intervention. Epidemiological studies have 
been conducted in Africa. In particular, they 
have shown that contrary to belief, the vacci-
nation of young dogs helps to increase immu-
nisation coverage in the canine population. 
Pilot studies (Tanzania) have demonstrated 
the feasibility of eradicating this disease at the 
regional level. Research findings are informing 
advocacy work, which is increasing. Success 
stories in the Philippines, Indonesia (Bali) and 
India have been recorded and disseminated. 
As a consequence, the media and the public 
authorities are giving greater attention to the 
disease. In 2015, OIE, FAO and WHO called 
for massive investment to eradicate it at the 
global level.
Another example is bovine tuberculosis, a 
disease affecting people with immuno- 
deficiency because of parasitic and viral 
diseases or malnutrition, whose eating habits 
put them at risk (consumption of unboiled 
milk). Ecological and epidemiological studies 
by CIRAD (see box p. 4) are helping to 
advance knowledge in these areas. In Southern 
Africa, they have identified factors and risks of 
bovine tuberculosis transmission between wild 
or domestic animal species and humans. Based 
on these results, the studies propose methods 
for optimising surveillance and better control-
ling this disease.
Finally, identifying a disease as neglected helps 
to attract, pool and sustain financing and to 
coordinate disease control efforts, a require-
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its findings on the ground, and also for mobi-
lising the private sector and distributing drugs 
and vaccines.
Hence the proposal to identify certain animal 
diseases as “neglected”. Although progress has 
been made on these diseases, it is not enough 
to address the challenges posed, whether in 
terms of scientific knowledge or of control 
measures. Interdisciplinary research is requir-
ed, associating biology, human science, social 
science (economics, health geography, socio-
logy, anthropology) and mathematics (model-
ling). The findings of this research will be used 
to inform control plans.
Identifying criteria and 
the threshold for recognition 
According to which criteria and from which 
threshold should an animal disease be officially 
recognised as neglected?
The first stage is to understand the production 
systems and activities of socially, economically 
or geographically marginalised populations 
that are impacted by the disease. This impact 
must then be evaluated: the risks it poses to 
household capital (loss of production) and to 
the functioning of markets and supply chains 
(lower prices, trade embargoes); and obstacles 
to intensification and modernisation, which 
keep households in the poverty trap. Contrary 
to human and zoonotic diseases, the criteria 
in this case are more economic and social in 
nature.
Other elements of context can be taken into 
consideration, such as the risk of the disease 
spreading to other countries. For example, 
African swine fever virus, which is endemic to 
sub-Saharan Africa, Russia and Eastern 
Europe, has attracted substantial interest from 
European governments and the European 
Commission… since it began to threaten 
Europe. This interest could create an opening 
that researchers, donors and industries could 
exploit (there is as yet no vaccine). Another 
example, lumpy skin disease, which is endemic 
to sub-Saharan Africa, is now emerging in the 
Middle East and Turkey. It is responsible for 
substantial economic losses in terms of meat 
and milk production and causes major losses 
to the leather industry. It can result in regional 
or international trade restrictions.
Other effects of the official recognition of a 
disease as “neglected” are worth highlighting. 
This recognition for infectious diseases (e.g. 
contagious bovine pleuropneumonia) or para-
sitic diseases (e.g. intestinal worms) whose 
treatment is not always well managed could 
contribute to reducing resistance to antibiotics 
and antiparasitics, a major problem and time 
bomb for public health. The adverse effects of 
treatments on pathogen resistance could be 
more closely studied in partnership with 
pharma- ceutical laboratories and users.
Studies by CIRAD (see box p.4) aimed at 
identifying prioritisation criteria and methods 
can be used to select the animal diseases to be 
recognised as “neglected”. Moving away from 
expert opinions, the goal of these studies is to 
develop more transparent, standardised and 
reproducible methods, using objective criteria: 
epidemiological data, impacts on animal pro-
duction, global economic costs, social impacts, 
resources available, etc.
The diseases to be tackled as a matter of prio-
rity can be defined by comparing cost-effecti-
veness ratios. The costs include those generated 
by disease control in the field; effectiveness is 
measured in physical units (litres of extra milk 
produced, working hours of plough oxen saved, 
etc.).
Tools and methodologies can be adapted, such 
as the DALY synthetic indicator or MCDA 
modelling. DALYs (Disability Adjusted Life 
Years) measure the burden of disease. They are 
calculated based on the number of years lost 
due to disability linked to poor health and to 
premature mortality because of disease. This 
indicator is used in (human) public health to 
compare the impacts of diseases and to eva-
luate health interventions, without the need 
for monetisation. A similar indicator could be 
developed for animal diseases. It would sup-
plement available impact indicators and help 
to better evaluate the socio-economic impacts 
of these diseases in order to prioritise them, 
then to assess the effectiveness of control mea-
sures.
MCDA (Multi-Criteria Decision Analysis) 
approaches are also interesting. They make it 
possible to combine different types of infor-
mation in spatial or non-spatial forms (for 
example, the socio-economic impacts of a 
disease and the methods implemented to 





A vast field of research thus needs to be explored. 
But to achieve this and to ensure access to the 
tools required to develop substantiated argu-
ments, it is essential to inform policy makers and 
stakeholders – international organisations, 
research donors, private foundations and labora-
tories – about the importance and benefits of 
identifying diseases as “neglected” in order to 
mobilise the human and financial resources 
needed. <
the threshold for recognition of a disease as 
neglected. Vulnerability mapping for human 
and animal populations produced by health 
geographers can be linked to health risk map-
ping drawn up by epidemiologists and geoma-
ticians. In addition to providing decision 
support for the identification of diseases as 
“neglected”, these can help to define the worst 
affected zones and populations, which should 
be targeted as a priority.
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This Perspective is the result of research in ecology, 
epidemiology, modelling, entomology, and econo-
mics conducted by several teams at CIRAD and 
their partners, on both zoonoses identified as 
“neglected” by WHO, and the socio-economic 
impacts and prioritisation of animal and zoonotic 
diseases.
On neglected zoonoses, research was conducted 
within the platforms in partnership GREASE 
(Management of Emerging Risks in Southeast Asia, 
http://www.grease-network.org/) and RP-PCP 
(Production and Conservation in Partnership 
Research Platform, http://www.rp-pcp.org/) and, 
for some diseases, in collaboration with the Institut 
Pasteur International Network. This research has 
given rise to several publications, including:
Caron A., de Garine-Wichatitsky M. & Roger F., 
2014. Bovine tuberculosis: a double-edged issue at 
the human/livestock/wildlife interface in Africa. In: 
FAO. EMPRES-Animal Health 360, n° 44. Rome.
http://www.fao.org/3/a-i4257e.pdf 
Tarantola A., Goutard F., Newton P., de Lamballerie 
X., Lortholary O., Cappelle J. et al., 2014. Estimating 
the Burden of Japanese Encephalitis Virus and 
Other Encephalitides in Countries of the Mekong 
Region. PLoS Negl Trop Dis 8(1): e2533. DOI: 
10.1371/journal.pntd.0002533
The InterTryp joint research unit (IRD-CIRAD) 
conducts research on human and animal 
trypanosomiasis within different programmes: 
http://umr-intertryp.cirad.fr/
On the socio-economic impacts of animal and 
zoonotic diseases and their prioritisation, research 
has been conducted or coordinated by the AGIRs 
unit (Animal and Integrated Risk Management, 
http://ur-agirs.cirad.fr/en), in particular in Ethiopia 
and Thailand: doctoral theses by students from the 
southern countries; summaries of activities in the 
least developed countries; and the ENHanCE pro-
ject with the University of Liverpool (http://bit.
ly/1M2x9Tq). These studies have given rise to seve-
ral publications, including:
Bordier M., Léger L., Kasemsuwan S., Wongnarkpet 
S. & Roger F., 2015. Methods for Prioritisation of 
Diseases: Case Study of Zoonoses in Southeast Asia. 
In: Socio-Ecological Dimensions of Infectious 
Diseases in Southeast Asia, p. 231-256. Springer-
Verlag Singapur.
http://www.springer.com/us/book/9789812875266
Gari G., Bonnet P., Roger F., Waret-Szkuta A., 
2011. Epidemiological aspects and financial impact 
of lumpy skin disease in Ethiopia. Prev Vet Med. 
102(4):274-83. doi: 10.1016/j.prevetmed.2011.07.003
Furthermore, as part of the ALive African Livestock 
programme, CIRAD has developed foresight tools 
for the quantitative evaluation of interventions and 
policies in livestock systems, supply chains and the 
economy of the sector, which are included in a tool-
box: V. Alary, C. Dutilly, P. Bonnet, M. Lesnoff, 
X. Juanes, 2014. Le guide Élevage-Pauvreté (LSIPT 
Livestock Sector Investment and Policy toolkit ) : 




Mableson H.E., Okello A., Picozzi K., Welburn S.C., 2014. 
Neglected zoonotic diseases-the long and winding road to 
advocacy. PLoS Negl Trop Dis. 2014 Jun 5;8(6):e2800. doi: 
10.1371/journal.pntd.0002800
Perry B.D., Grace D., Sones K., 2013. Current drivers and 
future directions of global livestock disease dynamics. Proc 
Natl Acad Sci USA. 110(52):20871-7. doi: 10.1073/
pnas.1012953108. 
Pigott D.M., Howes R.E., Wiebe A., Battle K.E., Golding 
N., Gething P.W., 2015. Prioritising Infectious Disease 
Mapping. PLoS Negl Trop Dis 9(6): e0003756. doi:10.1371/
journal.pntd.0003756
Thomson G. R., Fosgate G. T. and Penrith M.-L., 2015, 
Eradication of Transboundary Animal Diseases: Can the 
Rinderpest Success Story be Repeated? Transboundary and 
Emerging Diseases. doi: 10.1111/tbed.12385
A few words about…
François ROGER is a veterinarian 
and epidemiologist at CIRAD, 
where he leads the AGIRs 
research unit (http://ur-agirs.
cirad.fr/en). After several years 
working in sub-Saharan Africa, 
the Indian Ocean and Europe, 
he developed research 
programmes in Southeast Asia 
and launched the GREASE 
platform for research and 
training, which brings together 
different health sectors 
and disciplines according to 
the One Health approach.
francois.roger@cirad.fr
Pascal BONNET is a veterinarian 
and health geographer. He is 
Deputy Director of the 
Environments and Societies 
department at CIRAD. He has 
conducted research and 
provided scientific expertise in 
animal science and health 
geography and livestock 
economics in the Horn of Africa 
and Southern Africa, in 
partnership with international 
centres (ILRI, International 
Livestock Research Institute), 
national and regional structures 
(SADC, Southern African 
Development Community), 
NGOs (Action contre la faim) 
and agro-pastoral communities
pascal.bonnet@cirad.fr
  
